We have reported the establishment of a mitomycin-C (MMC)resistant non-small-cell lung-cancer cell line, PC-9/MC4. As determined by an MlT assay, this resistant cell line was found to be 4 times more sensitive to adriamycin (ADM) than was the parental PC-9. There were no significant differences in s
β¦ LIBER β¦
136 Thromboxane A2 as a determinant of sensitivity to platinum agents in non-small cell lung cancer cell lines
β Scribed by T. Bando; K. Kasahara; K. Shibata; M. Fujimura; T. Matsuda
- Book ID
- 116166894
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 144 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0959-8049
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
DT-diaphorase as a determinant of sensit
DT-diaphorase as a determinant of sensitivity to adriamycin in non-small-cell lung-cancer cell lines
β
Kazuo Kasahara; Kazuhiko Shibata; Takuma Bando; Yuka Numata; Masaki Fujimura; Ta
π
Article
π
1994
π
John Wiley and Sons
π
French
β 510 KB
DT-diaphorase as a determinant of sensit
DT-diaphorase as a determinant of sensitivity to adriamycin in non-small-cell lung-cancer cell lines
π
Article
π
1995
π
Elsevier Science
π
English
β 147 KB
Role of DT-diaphorase as a determinant o
π
Article
π
1995
π
Elsevier Science
π
English
β 143 KB
Thymidylate synthase as a determinant of
β
Takeda, M; Sakai, K; Tsukioka, S; Kuwata, K; Yamaguchi, H; Nishio, K; Nakagawa,
π
Article
π
2011
π
Nature Publishing Group
π
English
β 683 KB
127 Modulation of cis-diamminedichrolo-p
β
K. Kasahara; T. Bando; K. Shibata; Y. Numata; M. Fujimura; T. Matsuda
π
Article
π
1995
π
Elsevier Science
π
English
β 161 KB
Combined evaluation of Rad51 and ERCC1 e
β
Tomoyoshi Takenaka; Ichiro Yoshino; Hidenori Kouso; Taro Ohba; Tomofumi Yohena;
π
Article
π
2007
π
John Wiley and Sons
π
French
β 679 KB
## Abstract DNA repair enzyme expression in tumor cells possibly affects sensitivity to antiβcancer agents. The aim of this study was to determine the relationship between expression status of DNA repair enzymes and chemosensitivity in patients with nonβsmall cell lung cancer (NSCLC). NSCLC tissues